• Je něco špatně v tomto záznamu ?

Synthesis and anthelmintic activity of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives

V. Milišiūnaitė, A. Kadlecová, A. Žukauskaitė, K. Doležal, M. Strnad, J. Voller, E. Arbačiauskienė, W. Holzer, A. Šačkus

. 2020 ; 24 (4) : 1025-1042. [pub] 20191111

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026459

Grantová podpora
IGA_PrF_2019_020 Internal Grant Agency of Palacký University
CZ.02.1.01/0.0/0.0/16_019/0000868 Ministry of Education, Youth and Sports of the Czech Republic
LTC17072 Ministry of Education, Youth and Sports of the Czech Republic
P40 OD010440 ODCDC CDC HHS - United States
PP-91B/19 Research, Development and Innovation Fund of Kaunas University of Technology
P40 OD010440 ODCDC CDC HHS - United States

E-zdroje Online Plný text

NLK ProQuest Central od 1997-03-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-03-01 do Před 1 rokem

A series of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives were synthesized from readily available 1-phenyl- and 1-methyl-1H-pyrazol-3-ols by sequentially employing O-acylation, Fries rearrangement and potassium carbonate-induced cyclization. The anthelmintic properties of the obtained compounds were investigated in vivo in a model nematode, Caenorhabditis elegans. Five compounds, namely 2-phenyl[1]benzopyrano[2,3-c]pyrazol-4(2H)-one 33 and its 7-fluoro, 7-chloro-, 7-bromo- and 8-fluoro-analogues, 36, 38, 40 and 43, respectively, altered the development of C. elegans. While the activities of 33 and 43 were rather modest, compounds 36, 38 and 40 inhibited the growth of the worms at concentrations of approximately 1-3 µM. At these concentrations, the compounds did not kill the worms, but they strongly inhibited their development, with the majority of larvae never progressing past the L1 stage. Moreover, testing in non-cancer human cell lines showed that, with exception of 7-bromo derivative 40, the active compounds have favourable toxicity profiles.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026459
003      
CZ-PrNML
005      
20211026132907.0
007      
ta
008      
211013s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11030-019-10010-3 $2 doi
035    __
$a (PubMed)31713185
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Milišiūnaitė, Vaida $u Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254, Kaunas, Lithuania
245    10
$a Synthesis and anthelmintic activity of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives / $c V. Milišiūnaitė, A. Kadlecová, A. Žukauskaitė, K. Doležal, M. Strnad, J. Voller, E. Arbačiauskienė, W. Holzer, A. Šačkus
520    9_
$a A series of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives were synthesized from readily available 1-phenyl- and 1-methyl-1H-pyrazol-3-ols by sequentially employing O-acylation, Fries rearrangement and potassium carbonate-induced cyclization. The anthelmintic properties of the obtained compounds were investigated in vivo in a model nematode, Caenorhabditis elegans. Five compounds, namely 2-phenyl[1]benzopyrano[2,3-c]pyrazol-4(2H)-one 33 and its 7-fluoro, 7-chloro-, 7-bromo- and 8-fluoro-analogues, 36, 38, 40 and 43, respectively, altered the development of C. elegans. While the activities of 33 and 43 were rather modest, compounds 36, 38 and 40 inhibited the growth of the worms at concentrations of approximately 1-3 µM. At these concentrations, the compounds did not kill the worms, but they strongly inhibited their development, with the majority of larvae never progressing past the L1 stage. Moreover, testing in non-cancer human cell lines showed that, with exception of 7-bromo derivative 40, the active compounds have favourable toxicity profiles.
650    _2
$a zvířata $7 D000818
650    _2
$a anthelmintika $x chemická syntéza $x farmakologie $7 D000871
650    _2
$a Caenorhabditis elegans $x účinky léků $7 D017173
650    _2
$a buněčné linie $7 D002460
650    _2
$a cyklizace $x účinky léků $7 D003500
650    _2
$a lidé $7 D006801
650    _2
$a larva $x účinky léků $7 D007814
650    _2
$a pyrazoly $x chemie $7 D011720
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kadlecová, Alena $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
700    1_
$a Žukauskaitė, Asta $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
700    1_
$a Doležal, Karel $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic $u Department of Chemical Biology and Genetics, Faculty of Science, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
700    1_
$a Strnad, Miroslav $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
700    1_
$a Voller, Jiří $u Laboratory of Growth Regulators, Institute of Experimental Botany, The Czech Academy of Science, Palacký University, Šlechtitelů 27, 78371, Olomouc, Czech Republic
700    1_
$a Arbačiauskienė, Eglė $u Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, 50254, Kaunas, Lithuania. egle.arbaciauskiene@ktu.lt
700    1_
$a Holzer, Wolfgang $u Division of Drug Synthesis, Department of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, 1090, Vienna, Austria
700    1_
$a Šačkus, Algirdas $u Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, 51423, Kaunas, Lithuania. algirdas.sackus@ktu.lt
773    0_
$w MED00007776 $t Molecular diversity $x 1573-501X $g Roč. 24, č. 4 (2020), s. 1025-1042
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31713185 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132913 $b ABA008
999    __
$a ok $b bmc $g 1715241 $s 1146966
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 24 $c 4 $d 1025-1042 $e 20191111 $i 1573-501X $m Molecular diversity $n Mol Divers $x MED00007776
GRA    __
$a IGA_PrF_2019_020 $p Internal Grant Agency of Palacký University
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000868 $p Ministry of Education, Youth and Sports of the Czech Republic
GRA    __
$a LTC17072 $p Ministry of Education, Youth and Sports of the Czech Republic
GRA    __
$a P40 OD010440 $p ODCDC CDC HHS $2 United States
GRA    __
$a PP-91B/19 $p Research, Development and Innovation Fund of Kaunas University of Technology
GRA    __
$a P40 OD010440 $p ODCDC CDC HHS $2 United States
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...